Our data also clearly indicated that EGFR mutations are more likely to occur in TTF-1 positive tumors (145/675; 17.7%) than in TTF-1 negative adenocarcinomas (3/218; 1.4%). The gene discussed is TTF1; the disease is adenocarcinoma.